Journal
PHARMACEUTICAL RESEARCH
Volume 31, Issue 10, Pages 2583-2592Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11095-014-1353-z
Keywords
gemcitabine; gemcitabine-resistant pancreatic cancer cells; PEGylated liposome; remote loading; small volume incubation
Funding
- New Zealand Cancer Society [3627223]
- University of Auckland, New Zealand
Ask authors/readers for more resources
Purpose The objective of this study was to develop high-content gemcitabine PEGylated liposomes to reverse gemcitabine resistance in pancreatic tumour cells. The mechanism of drug loading into liposomes was also investigated. Methods To increase the drug entrapment efficiency (EE) and drug loading (DL), a novel passive loading approach named Small Volume Incubation method (SVI) was developed and compared to the reverse phase evaporation (REV) and remote loading methods. The in vitro cytotoxicity was evaluated using MIA PaCa-2 and Panc-1 cell lines. Results The EE for remote loading was 12.3 +/- 0.3%, much lower than expected and a burst release was observed with the resultant liposomes. Using the optimized SVI method, increased EE (37 +/- 1%) and DL (4%, w/w) were obtained. The liposomes (200 +/- 5 nm) showed minimal drug leakage, good stability, and significant improvement in cytotoxicity to the gemcitabine-resistant pancreatic cancer cell lines. Conclusions Remote loading was not suitable for loading gemcitabine into liposomes. pK(a)>4.6 for basic drugs and intra-liposomal precipitation of loaded compounds were suggested as an additional requirement to the current criteria for remote loading using ammonium sulphate gradient (pK(a)<11). High DL is essential for liposomes to reverse gemcitabine resistance in pancreatic cell lines.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available